Find Clinical Trials
A factorial randomised trial of blood pressure lowering with a fixed low-dose perindopril-indapamide combination and intensive glucose control with a modified-release gliclazide-based regimen for the prevention of vascular disease among high risk individuals with type 2 diabetes – ADVANCE
Servier Protocol Code:
CL3-05590-013
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2005-003281-41
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Diabetes - Type II
- Hypertension
- GLICLAZIDE
- INDAPAMIDE
- PERINDOPRIL TERT BUTYLAMINE
- S005590
- S005702
Other study id numbers
Other identification numbers the study may be known by.
- CL3-05590-013